bpc 157 safety evidence human studies BPC-157 – No Proof Required! | Office for Science and Society BPC-157: Experimental Peptide Creates Risk

1.64-fold for healthy and 2.23-fold for insulted cells)

THE PRODUCTS WE OFFER ARE NOT INTENDED FOR HUMAN USE

For patients waiting for access to physician-prescribed peptide protocols, the trajectory is clear

For a 5 mg vial, adding 2 mL of bacteriostatic water gives a 2,500 mcg/mL concentration where a 500 mcg dose equals 20 units on a U-100 insulin syringe

[DOI] [PMC free article] [PubMed] [Google Scholar] Metaxas C., Mathis D., Jeger C., Hersberger K

In each rat, two sterile sponges (1 cm x 1 cm x 0.25 cm (V=0.25 ml)) with the same quantities of NaBPC157, (solution50 g, 10 g, 10 ng/ml) or the reference agents, cimetidine (10 mg, 100 mg, 500 mg/ml), ranitidine (2.5 mg, 25 mg, 250 mg/ml), famotidine (10 mg, 50 mg, 100 mg/ml) and sucralfate (1 mg, 5 mg, 10 mg/ml) were implanted subcutaneously in the lumbar region